Observational studyInternal medicine (Tokyo, Japan)2023
Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan.
Eiji Mita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.